Presentations and Publications - November 2013

Presentations

"Collegiate Athlete with an Abnormal QT Interval on ECG"

Eugene Chung, MD, ACC Sports Cardiology Summit, October 2013

 

"Cases in PH, Dilemmas, from WHO Group 2"

Lisa Rose-Jones, MD, 5th Annual North Carolina Research Triangle Pulmonary Hypertension Symposium, November 8, 2013, Durham, NC

 

"Porsche By Design exhibition at NC Art Museum - American Cars and Hot Rods Meetup"

Jenni Hughes, MSN, RN,CCRN-CSC, Program Manager, Aortic Disease Management, November 9, 2013, Raleigh, NC

 

"Left Atrial Appendage Closure for Stroke Prophylaxis in Patients with Atrial Fibrillation"

Eugene Chung, MD, Cardiovascular Grand Rounds, November 11, 2013, Chapel Hill, NC

 

"Acute Heart Failure: A New Era or Same Old Problems?"

 Kirkwood Adams, MD (Moderator), AHA Scientific Sessions, November 17, 2013, Dallas, TX

 

"New Guideline Recommendations for Prevention and Control of Cardiovascular Risk Factors: From Diabetes to LDL Cholesterol Control"

Sidney Smith, MD, AHA Scientific Sessions, November 18, 2013, Dallas, TX

 

"Joint AHA/Brazilian Society of Cardiology Session: New Trends for Prevention and Diagnosis of Cardiovascular Disease"

Sidney Smith, MD, (Moderator), AHA Scientific Sessions, November 18, 2013, Dallas, TX

 

"Ventricular Tachycardia Events Are Associated with Admissions for Infection or Heart Failure in Patients with Left Ventricular Assist devices and Implantable Cardio-Defibrillators"

TJ O'Neill, MD (Fellow, Cardiology), AHA Scientific Sessions, November 18, 2013, Dallas, TX

 

"A Novel Implantable Cardio-Defibrillator Programming Strategy for Patients with Left Ventricular Assist Devices Reduces Shocks"

TJ O'Neill, MD (Fellow, Cardiology), AHA Scientific Sessions, November 18, 2013, Dallas, TX

 

"Guidelines: Is Contextualization Necessary?"

Sidney Smith, MD, AHA Scientific Sessions, November 19, 2013, Dallas, TX


"Medicare Part D Medication Use in a Community Cohort with Hypertension: The Atherosclerosis Risk in Communities (ARIC) Study"

Carla Sueta, MD, PhDAHA Scientific Sessions, November 19, 2013, Dallas, TX

 

"Current Role of AHA and ACC in Guidelines Development"

Sidney Smith, MDAHA Scientific Sessions, November 20, 2013, Dallas, TX

 

"Clinical Practice Guidelines for Prevention: Next Steps"

Sidney Smith, MD,  (Panelist), AHA Scientific Sessions, November 20, 2013, Dallas, TX

 

"VAD-Related Infections"

Jason Katz, MD, MHSAHA Scientific Sessions, November 20, 2013, Dallas, TX

 

Publications

Living in a medically underserved county is an independent risk factor for major limb amputation.

McGinigle KL, Kalbaugh CA, Marston WA.

J Vasc Surg. 2013 Nov 16. doi:pii: S0741-5214(13)01741-2. 10.1016/j.jvs.2013.09.037. [Epub ahead of print]

 

Biomarker Guided Therapy for Heart Failure: Focus on Natriuretic Peptides.

Pruett AE, Lee AK, Patterson JH, Schwartz TA, Glotzer JM, Adams KF.

Curr Cardiol Rev. 2013 Nov 17. [Epub ahead of print]

 

Adams et al. Respond to "Body Mass Index and Mortality"

Adams KF, Leitzmann MF, Ballard-Barbash R, Albanes D, Harris TB, Hollenbeck A.

Am J Epidemiol. 2013 Nov 11. [Epub ahead of print] No abstract available.

 

Soluble ST2 in Ambulatory Patients With Heart Failure: Association With Functional Capacity and Long-Term Outcomes.

Felker GM, Fiuzat M, Thompson V, Shaw LK, Neely ML, Adams KF, Whellan DJ, Donahue MP, Ahmad T, Kitzman DW, Piña IL, Zannad F, Kraus WE, O'Connor CM.

Circ Heart Fail. 2013 Nov 1;6(6):1172-1179. Epub 2013 Oct 8.

 

Advanced Therapies for End-Stage Heart Failure.

Katz JN, Waters SB, Hollis IB, Chang PP.

Curr Cardiol Rev. 2013 Nov 17. [Epub ahead of print]

 

Left atrial thrombus after appendage ligation with LARIAT.

Baker MS, Paul Mounsey J, Gehi AK, Chung EH.

Heart Rhythm. 2013 Nov 7. doi:pii: S1547-5271(13)01163-6. 10.1016/j.hrthm.2013.10.024. [Epub ahead of print] No abstract available.

 

The Effect of Anxiety and Depression on Symptoms Attributed to Atrial Fibrillation.

Thompson TS, Barksdale DJ, Sears SF, Mounsey JP, Pursell I, Gehi AK.

Pacing Clin Electrophysiol. 2013 Nov 11. doi: 10.1111/pace.12292. [Epub ahead of print]

 

Genetics and Heart Failure: A Concise Guide for the Clinician.

Skrzynia C, Berg JS, Willis MS, Jensen BC.

Curr Cardiol Rev. 2013 Nov 17. [Epub ahead of print]

 

Heart factory or fiction?: cardiac progenitor cells and regeneration.

Jensen BC, Patterson C.

Circulation. 2013 Nov 12;128(20):2181-2. doi: 10.1161/CIRCULATIONAHA.113.006262. Epub 2013 Oct 18. No abstract available.

 

Survival After Shock Therapy in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy-Defibrillator Recipients According to Rhythm Shocked: The ALTITUDE Survival by Rhythm Study.

Powell BD, Saxon LA, Boehmer JP, Day JD, Gilliam FR 3rd, Heidenreich PA, Jones PW, Rousseau MJ, Hayes DL.

J Am Coll Cardiol. 2013 Oct 29;62(18):1674-9. doi: 10.1016/j.jacc.2013.04.083. Epub 2013 Jun 27.

 

Pulmonary Hypertension: Types and Treatments.

Rose-Jones LJ, McLaughlin V.

Curr Cardiol Rev. 2013 Nov 17. [Epub ahead of print]

 

RE-LYing on Dabigatran for Periprocedural Anticoagulation: Is It Safe?

Bamimore A, Mounsey JP.

Pacing Clin Electrophysiol. 2013 Nov;36(11):1325-7. doi: 10.1111/pace.12217. Epub 2013 Jul 22. No abstract available.

 

Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A.

Du LM, Nurden P, Nurden AT, Nichols TC, Bellinger DA, Jensen ES, Haberichter SL, Merricks E, Raymer RA, Fang J, Koukouritaki SB, Jacobi PM, Hawkins TB, Cornetta K, Shi Q, Wilcox DA.

Nat Commun. 2013 Nov 19;4:2773. doi: 10.1038/ncomms3773.

 

The Ubiquitin Ligase CHIP Prevents SirT6 Degradation through Noncanonical Ubiquitination.

Ronnebaum SM, Wu Y, McDonough H, Patterson C.

Mol Cell Biol. 2013 Nov;33(22):4461-72. doi: 10.1128/MCB.00480-13. Epub 2013 Sep 16.

 

Orthostatic change in blood pressure and incidence of atrial fibrillation: results from a bi-ethnic population based study.

Agarwal SK, Alonso A, Whelton SP, Soliman EZ, Rose KM, Chamberlain AM, Simpson RJ Jr, Coresh J, Heiss G.

PLoS One. 2013 Nov 11;8(11):e79030. doi: 10.1371/journal.pone.0079030.

 

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson J, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW.

Circulation. 2013 Nov 12. [Epub ahead of print] No abstract available.

 

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Stone NJ, Robinson J, Lichtenstein AH, Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW.

Circulation. 2013 Nov 12. [Epub ahead of print] No abstract available.

 

2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Eckel RH, Jakicic JM, Ard JD, Hubbard VS, de Jesus JM, Lee IM, Lichtenstein AH, Loria CM, Millen BE, Miller NH, Nonas CA, Sacks FM, Smith SC Jr, Svetkey LP, Wadden TW, Yanovski SZ.

Circulation. 2013 Nov 12. [Epub ahead of print] No abstract available.

 

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Stone NJ, Robinson J, Lichtenstein AH, Bairey Merz CN, Lloyd-Jones DM, Blum CB, McBride P, Eckel RH, Schwartz JS, Goldberg AC, Shero ST, Gordon D, Smith SC Jr, Levy D, Watson K, Wilson PW.

J Am Coll Cardiol. 2013 Nov 7. doi:pii: S0735-1097(13)06028-2. 10.1016/j.jacc.2013.11.002. [Epub ahead of print] No abstract available.

 

2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Eckel RH, Jakicic JM, Ard JD, Miller NH, Hubbard VS, Nonas CA, de Jesus JM, Sacks FM, Lee IM, Smith SC Jr, Lichtenstein AH, Svetkey LP, Loria CM, Wadden TW, Millen BE, Yanovski SZ.

J Am Coll Cardiol. 2013 Nov 7. doi:pii: S0735-1097(13)06029-4. 10.1016/j.jacc.2013.11.003. [Epub ahead of print] No abstract available.

 

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Goff DC Jr, Lloyd-Jones DM, Bennett G, O'Donnell CJ, Coady S, Robinson J, D'Agostino RB Sr, Schwartz JS, Gibbons R, Shero ST, Greenland P, Smith SC Jr, Lackland DT, Sorlie P, Levy D, Stone NJ, Wilson PW.

J Am Coll Cardiol. 2013 Nov 7. doi:pii: S0735-1097(13)06031-2. 10.1016/j.jacc.2013.11.005. [Epub ahead of print] No abstract available.

 

Stage B: What is the Evidence for Treatment of Asymptomatic Left Ventricular Dysfunction?

Reed BN, Sueta CA.

Curr Cardiol Rev. 2013 Nov 17. [Epub ahead of print]

 

Stage A: Can Heart Failure Be Prevented?

Danelich IM, Reed BN, Sueta CA.

Curr Cardiol Rev. 2013 Nov 17. [Epub ahead of print]

 

A Practical Guide to the Treatment of Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF).

Reed BN, Sueta CA.

Curr Cardiol Rev. 2013 Nov 17. [Epub ahead of print]

 

Long-term clinical outcomes with the use of a modified provisional Jailed-Balloon stenting technique for the treatment of nonleft main coronary bifurcation lesions.

Depta JP, Patel Y, Patel JS, Novak E, Yeung M, Zajarias A, Kurz HI, Lasala JM, Bach RG, Singh J.

Share this: